Latest Breaking News On - Orrento announces publication ofa series of novel sars cov 2 main protease mpro inhibitors for potential treatment covid 19 patients infected with variants concern - Page 1 : comparemela.com

Sorrento Announces Publication of a Series of Novel SARS-CoV-2 Main Protease (MPRO) Inhibitors for Potential Treatment of COVID-19 Patients Infected With SARS-CoV-2 Variants Of Concern, Including Omicron - read this article along with other careers information, tips and advice on BioSpace

United statesHenry jiWenshe ray liuDorman followwillExchange commissionSorrento therapeutics incSemnur pharmaceuticals incTexasam universityScilex pharmaceuticals incProfessor liuGradipore chairSorrento therapeuticsPrivate securities litigation reform actAnnual reportQuarterly reportsInvestor relations